Pharmafile Logo
Pharmafocus logo
Advanced Search

AI

Showing 15 posts of 60 posts found.

uk

UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres

November 6, 2018
Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma

The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …

News
robot-1695653_1920

Robot addresses British MPs over future of AI

October 18, 2018
Medical Communications AI, Robot, UK, artificial intelligence, british parliament

British MPs questioned the first robot to ever attend a UK parliamentary meeting this month, after a robot called Pepper …

News
ai_robot

AI, big data: Making a case for faster drug discovery

October 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …

Feature
nhs_sign

UK Government to invest £200m in IT and technology boost for NHS

September 7, 2018
Medical Communications, Sales and Marketing AI, Matt Hancock, NHS, NHS expo, pharma

The UK Government has lifted the curtain on plans invest more than £200 million to leverage innovations in technology and …

News

AI used to forecast cancer progression

September 3, 2018
Sales and Marketing AI, Cancer, ICR, London, ai drug research and development, university of edinburgh

A team of scientists at the Institute of Cancer Research (ICR) in London and the University of Edinburgh have developed …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, AstraZeneca, Cancer, Gilead, HIV, J&J, JJ, google, machine learning, melanoma, pharma, top ten

The first day of June – time for another top ten run-down. It’s been a week somewhat characterised by trial …

News

NHS Trust harnesses AI to speed up treatment

May 22, 2018
Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …

News
joanna_shields

BenevolentAI names former UK Minister as new Group CEO

May 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

Appointment
heart_rope

Google develops AI to predict cardiovascular risk

February 21, 2018
Research and Development AI, Verily Life Sciences, biotech, cardiovascular, drugs, google, pharma, pharmaceutical

Google and Verily Life Sciences, a subsidiary within Alphabet, focused on developing health-tech, have revealed the fruits of a combined …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …

News
ai_graphic

The future is now: The transformative power of AI

February 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …

Feature
pharmafocus_janfeb__cover

Read Pharmafocus January/February 2018 edition online now!

January 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Ablynx, Alex Azr, Celgene, Pharmafocus, Sanofi, UK, artificial intelligence, bioverativ, brexit, juno therapeutics, multiple myeloma, serialisation

With the holiday period a distant memory by now, Pharmafocus is back with its January/febraury edition. It’s hard to imagine …

News
shutterstock_110597087-web

Skin cancer-detecting AI “on par with board-certified dermatologists”

January 27, 2017
Medical Communications, Research and Development AI, Cancer, skin cancer

New research has found that artificial intelligence repurposed by researchers at Stanford University to identify skin cancer in images has …

News
berg_niven_narain

Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015
Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …

Feature

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024